Occupational molybdenum exposure and a gouty electrician

Occupational Medicine

Volumn 55, Issue 2, 2005, Pages 145-148

  Seldén, Anders I ^a   Berg, N Peter ^a   Söderbergh, Annika ^a   Bergström, Bernt E O ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gout; Hyperuricaemia; Molybdenum; Occupational exposure

Indexed keywords

ALLOPURINOL; C REACTIVE PROTEIN; MOLYBDENUM; URATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; DISEASE ASSOCIATION; GOUT; HUMAN; HYPERHIDROSIS; HYPERURICEMIA; INDUSTRIAL WORKER; MALE; METATARSOPHALANGEAL JOINT; NAUSEA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; URIC ACID BLOOD LEVEL;

ADULT; ARTHRITIS, GOUTY; ELECTRICITY; GOUT; HUMANS; MALE; MOLYBDENUM; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE;

EID: 15944382686     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/kqi018     Document Type: Article

References (15)

1. Sardesai VM. Molybdenum: an essential trace element. Nutr Clin Pract 1993;8:277-281.
2. Wortmann RL. Gout and other disorders of purine metabolism. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine, vol. 2, 13th edn. New York: McGraw-Hill, Inc, 1994;2079-2088.
3. Friberg L, Lener J. Molybdenum. In: Friberg L, Nordberg G, Vouk VB, eds. Handbook on the Toxicology of Metals, Specific Metals vol. II, 2nd edn. Amsterdam: Elsevier, 1986;446-461.
4. United States Environmental Protection Agency. Molybdenum (CASRN 7439-98-7). Integrated Risk Information System (available 2003-12-23 at http://www.epa.gov/iris/subst/0425.htm).
5. American Conference of Governmental Industrial Hygienists. Molybdenum and compounds. Documentation for Threshold Limit Values. Cincinnati: ACGIH, 2000 (CD version).
6. Walravens PA, Moure-Eraso R, Solomons CC, Chappell WR, Bentley G. Biochemical abnormalities in workers exposed to molybdenum dust. Arch Environ Health 1979; 34:302-308.
7. National Institute for Occupational Safety and Health. Particulates not otherwise regulated, total. Method 0500. NIOSH Manual of Analytical Methods, 4th edn. Cincinnati: USDHHS, 1993.
8. Doherty M. Crystal-related arthropathies. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, vol. 3, 3rd edn. Oxford: Oxford University Press, 1996;2983-2992.
9. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20: 895-900.
10. Sugihara K, Kitamura S, Yamada T, et al. Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/ xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodi-benzo-p dioxin. Biochem Biophys Res Commun 2001;281: 1093-1099.
11. Johnson C, Stubley-Beedham C, Stell JG. Elevation of molybdenum hydroxylase levels in rabbit liver after ingestion of phthalazine or its hydroxylated metabolite. Biochem Pharmacol 1984;33:3699-3705.
12. Iversen BS, Menné C, White MA, Kristiansen J, Molin Christensen J, Sabbioni E. Inductively coupled plasma mass spectrometric determination of molybdenum in urine from a Danish population. Analyst 1998;123:81-85.
13. Barceloux DG. Molybdenum. Clin Toxicol 1999;37: 231-237.
14. Seidel S, Kreutzer R, Smith D, McNeel S, Gilliss D. Assessment of commercial laboratories performing hair mineral analysis. J Am Med Assoc 2001;285:67-72.
15. Harkins DK, Susten AS. Meeting report: hair analysis: exploring the state of the science. Environ Health Perspect 2003; 111:576-578.